Changes for page Square Pharmaceuticals Ltd
Last modified by Wilton Risenhoover on 2022/07/06 01:17
edited by Md. Touhidul Islam
on 2021/09/15 07:12
on 2021/09/15 07:12
edited by Md. Touhidul Islam
on 2021/09/15 07:43
on 2021/09/15 07:43
Change comment:
There is no comment for this version
Summary
-
Page properties (1 modified, 0 added, 0 removed)
Details
- Page properties
-
- Content
-
... ... @@ -4,6 +4,10 @@ 4 4 5 5 = Summary = 6 6 7 +* The company was established in 1958 as a partnership firm by Late Samson H. Chowdhury. 8 +* General public holds 36.25% of the total shares; sponsors, foreigners, and institutions hold 34.57%, 18.61%, and 10.57%, respectively. The company has an authorised capital of Tk 10,000 million and paid-up capital of Tk 8,864.51 million. 9 +* The production units of the company are basically two types – primary, and secondary units. 10 +* The company earn BDT 12.96 billion profit after tax (PAT) during the same year, a 22.66% growth year on year. Net asset value (NAV) stood at 69.85 million, a 14.87% increase year on year. Earnings per share of the company has grown 22.66% and stood at BDT 15.35 during the same year. The company paid cash dividend of BDT 3.97 billion during FY20. 7 7 8 8 = Company overview = 9 9 ... ... @@ -118,5 +118,4 @@ 118 118 119 119 * The company will start its operation in the Kenya by this year 120 120 121 - 122 122 {{putFootnotes/}}